Skip to main content
Signal8

Wesolowski John M

SEC insider (Form 3/4/5 filer). CIK 0001895944. Principal Accounting Officer at INTENSITY THERAPEUTICS, INC. (INTS). 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in SHELTON, CT.

Companies Wesolowski John M has filed insider reports for

  • INTENSITY THERAPEUTICS, INC. (INTS): Officer, Principal Accounting Officer
Wesolowski John M profile photo

Wesolowski John M

CIK: 0001895944

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INTENSITY THERAPEUTICS, INC. logo
INTS

INTENSITY THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    Jul 16, 2026
    Award

    Stock Option (right to buy Common Stock)

    Direct
    11K shares-
  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    Jun 30, 2026
    Award
    Direct
    3.7K shares at avg. $3.48$13K
  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    Dec 31, 2025
    Award
    Direct
    8.9K shares at avg. $0.26$2K
  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    Jun 30, 2025
    Award
    Direct
    69.7K shares at avg. $0.26$18K
  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    May 2, 2025
    Award

    Stock Option (right to buy Common Stock)

    Direct
    100K shares-
  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    May 2, 2025
    Award

    Stock Option (right to buy Common Stock)

    Direct
    100K shares-
  • INTENSITY THERAPEUTICS, INC. logo
    INTS

    INTENSITY THERAPEUTICS, INC.

    Oct 21, 2024
    Award

    Stock Option (right to buy Common Stock)

    Direct
    70K shares-

1-7 of 7